BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sokullu E, Gauthier MS, Coulombe B. Discovery of Antivirals Using Phage Display. Viruses 2021;13:1120. [PMID: 34200959 DOI: 10.3390/v13061120] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Bisht D, Sajjanar BK, Saxena S, Kakodia B, Dighe V, Thakuria D, Kharayat NS, Chanu KV, Kumar S. Identification and characterization of phage display-selected peptides having affinity to Peste des petits ruminants virus. J Immunol Methods 2023;515:113455. [PMID: 36893896 DOI: 10.1016/j.jim.2023.113455] [Reference Citation Analysis]
2 Sharma K, Sharma KK, Sharma A, Jain R. Peptide-based drug discovery: Current status and recent advances. Drug Discov Today 2023;28:103464. [PMID: 36481586 DOI: 10.1016/j.drudis.2022.103464] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
3 Huh H, Chen DW, Foldvari M, Slavcev R, Blay J. EGFR-targeted bacteriophage lambda penetrates model stromal and colorectal carcinoma tissues, is taken up into carcinoma cells, and interferes with 3-dimensional tumor formation. Front Immunol 2022;13:957233. [PMID: 36591314 DOI: 10.3389/fimmu.2022.957233] [Reference Citation Analysis]
4 Wang T, Xu J, Wang B, Wang Y, Zhao W, Xiang B, Xue Y, Yuan Q, Wang Y. Receptor-binding domain-anchored peptides block binding of severe acute respiratory syndrome coronavirus 2 spike proteins with cell surface angiotensin-converting enzyme 2. Front Microbiol 2022;13:910343. [DOI: 10.3389/fmicb.2022.910343] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Parra AL, Bezerra LP, Shawar DE, Neto NA, Mesquita FP, da Silva GO, Souza PF. Synthetic antiviral peptides: a new way to develop targeted antiviral drugs. Future Virology. [DOI: 10.2217/fvl-2021-0308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Huang S, Wu Y, Su L, Su T, Zhou Q, Zhang J, Zhao Z, Weng S, He J, Xie J. A single-chain variable fragment antibody exerts anti-nervous necrosis virus activity by irreversible binding. Aquaculture 2022;552:738001. [DOI: 10.1016/j.aquaculture.2022.738001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Liu X, Sui J, Li C, Peng X, Wang Q, Jiang N, Xu Q, Wang L, Lin J, Zhao G. Preparation of a Nanobody Specific to Dectin 1 and Its Anti-inflammatory Effects on Fungal Keratitis. IJN 2022;Volume 17:537-51. [DOI: 10.2147/ijn.s338974] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Lundblad RL. Drug Design. Reference Module in Life Sciences 2022. [DOI: 10.1016/b978-0-12-821618-7.00071-7] [Reference Citation Analysis]
9 Davydova EK. Protein Engineering: Advances in Phage Display for Basic Science and Medical Research. Biochemistry Moscow 2022;87:S146-S167. [DOI: 10.1134/s0006297922140127] [Reference Citation Analysis]
10 Wu N, Chen LK, Zhu T. Phage therapy for secondary bacterial infections with COVID-19. Curr Opin Virol 2021;52:9-14. [PMID: 34800893 DOI: 10.1016/j.coviro.2021.11.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]